Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
ROCHESTER, Minn. — A Mayo Clinic review of patients' responses to a drug used to control nausea and vomiting during anesthesia for general surgery questions a U.S. Food and Drug Administration (FDA) warning against the drug's use. This study appears in the current issue of the journal Anesthesiology.